These potential negative effects of PTEN inhibition warrant stringent testing for possible tumorigenesis and metabolic illnesses such as diabetes, hypertension, and cardiovascular disease in the mice that are generated by the fertilization of oocytes obtained from PTEN inhibitor-treated ovaries. This evidence concerns the gene PTEN and diabetes mellitus.